SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
EMCORE Corporation (EMKR) .
Criteria proven by this page:
- VALUE (20/100, Fail) — analyst consensus target implies downside from the current price ($2.50, 19.2%).
- Analyst consensus target $2.50 (-19.2% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 33/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
20/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EMKR
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.33
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-3.46
Book Value / Share$0.00
Revenue / Share$9.52
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$2.50 (-19.2%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$2.10 |
$81.69M |
$63.1M |
77.2% |
| 2016 |
$0.31 |
$92M |
$8.27M |
9% |
| 2017 |
$0.30 |
$122.9M |
$8.24M |
6.7% |
| 2018 |
$-0.64 |
$85.62M |
$-17.45M |
-20.4% |
| 2019 |
$-12.86 |
$87.27M |
$-35.98M |
-41.2% |
| 2020 |
$-2.40 |
$110.13M |
$-7M |
-6.4% |
| 2021 |
$7.17 |
$158.44M |
$25.64M |
16.2% |
| 2022 |
$-6.53 |
$124.13M |
$-24.33M |
-19.6% |
| 2023 |
$-14.63 |
$97.72M |
$-76.41M |
-78.2% |
| 2024 |
$-3.46 |
$85.9M |
$-31.24M |
-36.4% |
